These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24293346)
1. Novel therapies for treating familial hypercholesterolemia. Bandeali SJ; Daye J; Virani SS Curr Atheroscler Rep; 2014 Jan; 16(1):382. PubMed ID: 24293346 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies? Roy G; Drouin-Chartier JP Curr Opin Lipidol; 2024 Feb; 35(1):1-6. PubMed ID: 37910156 [TBL] [Abstract][Full Text] [Related]
3. LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes. Santos RD; Cuchel M Circulation; 2024 Jan; 149(5):363-366. PubMed ID: 38285739 [No Abstract] [Full Text] [Related]
4. Pharmacotherapy in familial hypercholesterolemia - Current state and emerging paradigms. Kallapur A; Sallam T Trends Cardiovasc Med; 2023 Apr; 33(3):170-179. PubMed ID: 34968676 [TBL] [Abstract][Full Text] [Related]
5. Predictors of cardiovascular risk in familial hypercholesterolemia. Romero-Jiménez MJ; Mansilla-Rodríguez ME; Gutiérrez-Cortizo EN Curr Opin Lipidol; 2023 Dec; 34(6):272-277. PubMed ID: 37769168 [TBL] [Abstract][Full Text] [Related]
6. A new non-human primate model of familial hypercholesterolemia. Ferreira J Lab Anim (NY); 2023 Nov; 52(11):266. PubMed ID: 37891349 [No Abstract] [Full Text] [Related]
19. Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Jia X; Al Rifai M; Liu J; Agarwala A; Gulati M; Virani SS Curr Atheroscler Rep; 2020 Jun; 22(8):32. PubMed ID: 32556778 [TBL] [Abstract][Full Text] [Related]